PER percheron therapeutics limited

Ann: Topline Six-Month Results From Phase IIb Study of Avicursen, page-63

  1. 416 Posts.
    lightbulb Created with Sketch. 207
    Company should have roughly $18 million cash on hand by my estimates. 1 billion shares on issue. Spend is going to go way down with the trial being discontinued. I'd imagine several staff will be laid off shortly. IP can be auctioned off for scrap.

    Company is easily worth more than 1 cent. Not much more. But more than 1 cent.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $6.54K 654.0K

Buyers (Bids)

No. Vol. Price($)
13 3200792 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 2466000 5
View Market Depth
Last trade - 09.59am 27/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.